Search
for
Sort by
Research 391–420 of 1000+
- 075 Clinical investigation of JAK inhibitor Tofacitinib in scarring alopecias
- 378 Treatment of severe alopecia areata with the oral Janus kinase inhibitor, tofacitinib: A retrospective chart review
- Epidermis-specific ablation of claudin-1 in adult mice demonstrates the essential role of a tight junction barrier in skin homeostasis
- The JID Legacy Project: Introspecting on Our Past
- Introduction to JID Symposium Proceedings 52nd Annual Montagna Symposium on the Biology of Skin “Stem Cells in Skin” Held at Snowmass, Colorado, USA, June 13–17, 2003
- 0527 Effectiveness of janus kinase inhibitor for rapidly progressive acute alopecia areata
- 75993 Safety of Janus kinase inhibitors for treatment of alopecia areata
- 73192 Consistent Efficacy of Upadacitinib in Alopecia Areata Subgroups: Adult, Pediatric, Severe Disease, and JAK-Refractory Patients — A Meta-Analysis
- 75360 Nasal hair (vibrissae) involvement in patients with alopecia areata universalis: preliminary results showing density modification and response to oral JAK inhibitors
- 72751 Janus Kinase Inhibitors for Alopecia Universalis: A Systematic Review
- 77200 Infections and Therapy Lapses Predominate as Flare Triggers on Oral JAK Inhibitors for Alopecia Areata: A Retrospective Cohort Study
- 73571 The real-world impact of JAK inhibitor treatment on anxiety and depression outcomes and the role of eyebrow and eyelash hair regrowth in alopecia areata: TARGET-DERM
- Paternal finasteride exposure and its impact on offspring testicular histopathology and intracellular junctions: the role of occludin and N-cadherin
- <div>Six years of the IP Indian Journal of Clinical and Experimental Dermatology (2019-2025):&nbsp;<span style="font-size: 1rem;">A bibliometric and thematic analysis</span></div>
- Therapeutic potential of orally administered Connarus semidecandrus Jack ethanol extract in an androgenetic alopecia model
- Response to Javaheri et al., “Topical estrogens: Use in hair loss and additional safety concerns for consideration”
- Justicia procumbens promotes hair growth and ameliorates age-related deterioration of hair health
- 455 Beyond Immunity: TEC and JAK3 Kinase Activation in Melanocytes Drives Inflammation in Vitiligo
- 448 Combined therapeutic approach: Inhibition of MMP-9 and JAK Signaling Synergistically Prevents Depigmentation in Experimental Vitiligo
- 126 Itch of Dermatomyositis treated with topical JAK inhibitor
- Two’s Company, Three’s a Hair Cycle? hfDSCs Join the Hair Germ–Dermal Papilla Regulatory Interface
- 63407 A Descriptive Analysis of Patients With Moderate-to-Severe Atopic Dermatitis and Comorbid Alopecia Areata in the Abrocitinib JADE Clinical Program
- Strength and Tenderness: Fibronectin Joins Hair Follicle Stem Cell Niche
- 0433 JAK inhibitor halts the progression of acute exacerbation of alopecia areata
- 0350 Impact of switching janus kinase inhibitors in the treatment of severe alopecia areata
- 0873 Modeling junctional epidermolysis bullosa using tissue-engineered skin substitutes
- Highlights from JAAD Reviews: August 2025—Bicalutamide for female hair loss
- 54457 Gratitude Journals as an Adjunct Intervention for Female Pattern Hair Loss
- Age-Related Progression of Androgenetic Alopecia: Statistical Analysis in 5,372 Japanese Men
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties